Patents by Inventor Darren Reece WILLIAMS

Darren Reece WILLIAMS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising organoselenium compound for treatment of skeletal muscle atrophy
    Patent number: 11878003
    Abstract: This application relates to a composition for preventing, treating, and improving skeletal muscle atrophy, the composition including an organoselenium compound. The composition recovered the thickness of muscle fiber reduced by dexamethasone treatment. In addition, the treatment of mice in a muscle loss model showed that the composition had an effect of reducing damaged muscle and of restoring muscle mass. Therefore, it is expected that the composition can be effectively used for the treatment, prevention, or improvement of muscle atrophy.
    Type: Grant
    Filed: September 24, 2021
    Date of Patent: January 23, 2024
    Assignee: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Darren Reece Williams, Da-Woon Jung, Ji-Hyung Lee, Hyun-Jun Kim, Seon-Wook Kim
  • METHOD FOR SCREENING MARKERS FOR PREDICTING PROGNOSIS OF RENAL CELL CARCINOMA USING TRANSCRIPTOMIC ANALYSIS
    Publication number: 20230242993
    Abstract: A marker composition for predicting RCC prognosis, includes at least one gene selected from the group consisting of DUSP22, MAPK14, MAPKAPK3, STAT1, and VCP, discovered by the screening method of the present invention, or a protein encoded by the gene, and a pharmaceutical composition for treating RCC, includes a DUSP22 inhibitor of the present invention as an active ingredient.
    Type: Application
    Filed: November 24, 2022
    Publication date: August 3, 2023
    Applicant: Gwangju Institute of Science and Technology
    Inventors: Hyun Ju LEE, Darren Reece Williams, Eui Young OH, Da Woon JUNG, Jun Hyeong KIM
  • COMPOSITION COMPRISING ORGANOSELENIUM COMPOUND FOR TREATMENT OF SKELETAL MUSCLE ATROPHY
    Publication number: 20230210818
    Abstract: This application relates to a composition for preventing, treating, and improving skeletal muscle atrophy, the composition including an organoselenium compound. The composition recovered the thickness of muscle fiber reduced by dexamethasone treatment. In addition, the treatment of mice in a muscle loss model showed that the composition had an effect of reducing damaged muscle and of restoring muscle mass. Therefore, it is expected that the composition can be effectively used for the treatment, prevention, or improvement of muscle atrophy.
    Type: Application
    Filed: September 24, 2021
    Publication date: July 6, 2023
    Inventors: Darren Reece WILLIAMS, Da-Woon JUNG, Ji-Hyung LEE, Hyun-Jun KIM, Seon-Wook KIM